X0508 4 2026-01-16 0 0001326110 ImmunityBio, Inc. IBRX 0001849739 Selecky Christobel C/O IMMUNITYBIO, INC. 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121 1 0 0 0 1 Common Stock 2026-01-16 4 M 0 50000 2.98 A 50000 D Common Stock 2026-01-16 4 S 0 50000 5 D 0 D Common Stock 2026-01-20 4 M 0 25000 2.98 A 25000 D Common Stock 2026-01-20 4 S 0 25000 7.506 D 0 D Stock Option (right to buy) 2.98 2026-01-16 4 M 0 50000 0 D 2032-06-14 Common Stock 50000 117937 D Stock Option (right to buy) 2.98 2026-01-20 4 M 0 25000 0 D 2032-06-14 Common Stock 25000 92937 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2025. Represents the weighted average share price of an aggregate total of 25,000 shares sold in the price range of $7.50 to $7.52 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. One hundred percent (100%) of the shares subject to the award vested on June 12, 2023, the date immediately preceding the 2023 annual meeting of stockholders. Exhibit 24 - Power of Attorney /s/ Philip LoScalzo, as Attorney-in-Fact 2026-01-21